|
|
Blood, 1 April 2005, Vol. 105, No. 7, pp. 2757-2763.
Prepublished online as a Blood First Edition Paper on November 30, 2004; DOI 10.1182/blood-2004-08-3317.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Hematopoietic cells regulate the angiogenic switch during tumorigenesis
Rika Okamoto,
Masaya Ueno,
Yoshihiro Yamada,
Naoko Takahashi,
Hideto Sano,
Toshio Suda, and
Nobuyuki Takakura
From the Department of Stem Cell Biology, Cancer Research Institute of Kanazawa University, Japan; and the Department of Cell Differentiation, The Sakaguchi Laboratory of Developmental Biology, School of Medicine, Keio University, Tokyo, Japan.
Hematopoietic cells (HCs) promote blood vessel formation by producing various proangiogenic cytokines and chemokines and matrix metalloproteinases. We injected mouse colon26 colon cancer cells or human PC3 prostate adenocarcinoma cells into mice and studied the localization of HCs during tumor development. HCs were distributed in the inner tumor mass in all of the tumor tissues examined; however, the localization of HCs in the tumor tissue differed depending on the tumor cell type. In the case of colon26 tumors, as the tumor grew, many mature HCs migrated into the tumor mass before fine capillary formation was observed. On the other hand, although very few HCs migrated into PC3 tumor tissue, c-Kit+ hematopoietic stem/progenitor cells accumulated around the edge of the tumor. Bone marrow suppression induced by injection of antic-Kit neutralizing antibody suppressed tumor angiogenesis by different mechanisms according to the tumor cell type: bone marrow suppression inhibited the initiation of sprouting angiogenesis in colon26 tumors, while it suppressed an increase in the caliber of newly developed blood vessels at the tumor edge in PC3 tumors. Our findings suggest that HCs are involved in tumor angiogenesis and regulate the angiogenic switch during tumorigenesis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. K. Hirschi, D. A. Ingram, and M. C. Yoder
Assessing Identity, Phenotype, and Fate of Endothelial Progenitor Cells
Arterioscler Thromb Vasc Biol,
September 1, 2008;
28(9):
1584 - 1595.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. He, H. Hu, R. Braren, S.-Y. Fong, A. Trumpp, T. R. Carlson, and R. A. Wang
c-myc in the hematopoietic lineage is crucial for its angiogenic function in the mouse embryo
Development,
July 15, 2008;
135(14):
2467 - 2477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Purhonen, J. Palm, D. Rossi, N. Kaskenpaa, I. Rajantie, S. Yla-Herttuala, K. Alitalo, I. L. Weissman, and P. Salven
Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth
PNAS,
May 6, 2008;
105(18):
6620 - 6625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-Y. Katoh, M. Ueno, and N. Takakura
Involvement of MDR1 Function in Proliferation of Tumour Cells
J. Biochem.,
April 1, 2008;
143(4):
517 - 524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wels, R. N. Kaplan, S. Rafii, and D. Lyden
Migratory neighbors and distant invaders: tumor-associated niche cells
Genes & Dev.,
March 1, 2008;
22(5):
559 - 574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Huang, Y. Yamada, H. Kidoya, H. Naito, Y. Nagahama, L. Kong, S.-Y. Katoh, W.-l. Li, M. Ueno, and N. Takakura
EphB4 Overexpression in B16 Melanoma Cells Affects Arterial-Venous Patterning in Tumor Angiogenesis
Cancer Res.,
October 15, 2007;
67(20):
9800 - 9808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Venneri, M. D. Palma, M. Ponzoni, F. Pucci, C. Scielzo, E. Zonari, R. Mazzieri, C. Doglioni, and L. Naldini
Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer
Blood,
June 15, 2007;
109(12):
5276 - 5285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Yoder, L. E. Mead, D. Prater, T. R. Krier, K. N. Mroueh, F. Li, R. Krasich, C. J. Temm, J. T. Prchal, and D. A. Ingram
Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals
Blood,
March 1, 2007;
109(5):
1801 - 1809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-L. Li, Y. Yamada, M. Ueno, S. Nishikawa, S.-I. Nishikawa, and N. Takakura
Platelet Derived Growth Factor Receptor Alpha Is Essential for Establishing a Microenvironment That Supports Definitive Erythropoiesis
J. Biochem.,
August 1, 2006;
140(2):
267 - 273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yamada and N. Takakura
Physiological pathway of differentiation of hematopoietic stem cell population into mural cells
J. Exp. Med.,
April 17, 2006;
203(4):
1055 - 1065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Huang, C. Brown, W. Ni, E. Maynard, A. C. Rigby, and P. Oettgen
Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis
Blood,
April 15, 2006;
107(8):
3153 - 3160.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|